FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116546005: Pheniramine maleate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177264010 Pheniramine maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
679536016 Pheniramine maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
832751000172116 maléate de phéniramine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pheniramine maleate Is a Product containing pheniramine (medicinal product) false Inferred relationship Some
Pheniramine maleate Is a Pheniramine (substance) false Inferred relationship Some
Pheniramine maleate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine receptor antagonist (disposition) false Inferred relationship Some
Pheniramine maleate Is a Propylamine derivative antihistamine true Inferred relationship Some
Pheniramine maleate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Pheniramine (substance) true Inferred relationship Some
Pheniramine maleate Is a Histamine H1 receptor antagonist true Inferred relationship Some
Pheniramine maleate Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. true Inferred relationship Some
Pheniramine maleate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine H1 receptor antagonist (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Naphazoline hydrochloride+pheniramine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pheniramine maleate Inferred relationship Some
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pheniramine maleate Inferred relationship Some
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pheniramine maleate Inferred relationship Some 1
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pheniramine maleate Inferred relationship Some 1
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pheniramine maleate Inferred relationship Some 1
Naphazoline hydrochloride 270 microgram/mL and pheniramine maleate 3.15 mg/mL eye solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pheniramine maleate Inferred relationship Some 1
Pheniramine maleate 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pheniramine maleate Inferred relationship Some 1
Pheniramine maleate 25 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pheniramine maleate Inferred relationship Some 1
Product containing precisely pheniramine maleate 22.75 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Pheniramine maleate Inferred relationship Some 1
Product containing precisely pheniramine maleate 22.75 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Pheniramine maleate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start